IBDEI25Y ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,34543,2)
;;=^5003400
;;^UTILITY(U,$J,358.3,34544,0)
;;=F18.959^^134^1751^15
;;^UTILITY(U,$J,358.3,34544,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34544,1,3,0)
;;=3^Inhalant Induced Psychotic D/O w/o Use D/O
;;^UTILITY(U,$J,358.3,34544,1,4,0)
;;=4^F18.959
;;^UTILITY(U,$J,358.3,34544,2)
;;=^5003412
;;^UTILITY(U,$J,358.3,34545,0)
;;=F18.99^^134^1751^22
;;^UTILITY(U,$J,358.3,34545,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34545,1,3,0)
;;=3^Inhalant Related D/O,Unspec
;;^UTILITY(U,$J,358.3,34545,1,4,0)
;;=4^F18.99
;;^UTILITY(U,$J,358.3,34545,2)
;;=^5133360
;;^UTILITY(U,$J,358.3,34546,0)
;;=F18.21^^134^1751^25
;;^UTILITY(U,$J,358.3,34546,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34546,1,3,0)
;;=3^Inhalant Use D/O,Mod/Sev,In Remission
;;^UTILITY(U,$J,358.3,34546,1,4,0)
;;=4^F18.21
;;^UTILITY(U,$J,358.3,34546,2)
;;=^5003393
;;^UTILITY(U,$J,358.3,34547,0)
;;=F18.11^^134^1751^24
;;^UTILITY(U,$J,358.3,34547,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34547,1,3,0)
;;=3^Inhalant Use D/O,Mild,In Remission
;;^UTILITY(U,$J,358.3,34547,1,4,0)
;;=4^F18.11
;;^UTILITY(U,$J,358.3,34547,2)
;;=^5151305
;;^UTILITY(U,$J,358.3,34548,0)
;;=Z00.6^^134^1752^1
;;^UTILITY(U,$J,358.3,34548,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34548,1,3,0)
;;=3^Exam Control in Clinical Research
;;^UTILITY(U,$J,358.3,34548,1,4,0)
;;=4^Z00.6
;;^UTILITY(U,$J,358.3,34548,2)
;;=^5062608
;;^UTILITY(U,$J,358.3,34549,0)
;;=F45.8^^134^1753^13
;;^UTILITY(U,$J,358.3,34549,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34549,1,3,0)
;;=3^Somatoform Symp & Rel D/O,Oth Spec
;;^UTILITY(U,$J,358.3,34549,1,4,0)
;;=4^F45.8
;;^UTILITY(U,$J,358.3,34549,2)
;;=^331915
;;^UTILITY(U,$J,358.3,34550,0)
;;=F45.0^^134^1753^12
;;^UTILITY(U,$J,358.3,34550,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34550,1,3,0)
;;=3^Somatization D/O
;;^UTILITY(U,$J,358.3,34550,1,4,0)
;;=4^F45.0
;;^UTILITY(U,$J,358.3,34550,2)
;;=^112280
;;^UTILITY(U,$J,358.3,34551,0)
;;=F45.9^^134^1753^14
;;^UTILITY(U,$J,358.3,34551,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34551,1,3,0)
;;=3^Somatoform Symp & Rel D/O,Unspec
;;^UTILITY(U,$J,358.3,34551,1,4,0)
;;=4^F45.9
;;^UTILITY(U,$J,358.3,34551,2)
;;=^5003592
;;^UTILITY(U,$J,358.3,34552,0)
;;=F45.1^^134^1753^11
;;^UTILITY(U,$J,358.3,34552,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34552,1,3,0)
;;=3^Somatic Symptom D/O
;;^UTILITY(U,$J,358.3,34552,1,4,0)
;;=4^F45.1
;;^UTILITY(U,$J,358.3,34552,2)
;;=^5003585
;;^UTILITY(U,$J,358.3,34553,0)
;;=F44.4^^134^1753^4
;;^UTILITY(U,$J,358.3,34553,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34553,1,3,0)
;;=3^Conversion D/O w/ Motor Symp or Deficit
;;^UTILITY(U,$J,358.3,34553,1,4,0)
;;=4^F44.4
;;^UTILITY(U,$J,358.3,34553,2)
;;=^5003579
;;^UTILITY(U,$J,358.3,34554,0)
;;=F44.6^^134^1753^1
;;^UTILITY(U,$J,358.3,34554,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34554,1,3,0)
;;=3^Conversion D/O w/ Anesthesia or Sensory Loss
;;^UTILITY(U,$J,358.3,34554,1,4,0)
;;=4^F44.6
;;^UTILITY(U,$J,358.3,34554,2)
;;=^5003581
;;^UTILITY(U,$J,358.3,34555,0)
;;=F44.5^^134^1753^2
;;^UTILITY(U,$J,358.3,34555,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34555,1,3,0)
;;=3^Conversion D/O w/ Attacks or Seizures
;;^UTILITY(U,$J,358.3,34555,1,4,0)
;;=4^F44.5
;;^UTILITY(U,$J,358.3,34555,2)
;;=^5003580
;;^UTILITY(U,$J,358.3,34556,0)
;;=F44.7^^134^1753^3
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI25Y 3793 printed Nov 22, 2024@17:32:35 Page 2
IBDEI25Y ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,34543,2)
+2 ;;=^5003400
+3 ;;^UTILITY(U,$J,358.3,34544,0)
+4 ;;=F18.959^^134^1751^15
+5 ;;^UTILITY(U,$J,358.3,34544,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,34544,1,3,0)
+8 ;;=3^Inhalant Induced Psychotic D/O w/o Use D/O
+9 ;;^UTILITY(U,$J,358.3,34544,1,4,0)
+10 ;;=4^F18.959
+11 ;;^UTILITY(U,$J,358.3,34544,2)
+12 ;;=^5003412
+13 ;;^UTILITY(U,$J,358.3,34545,0)
+14 ;;=F18.99^^134^1751^22
+15 ;;^UTILITY(U,$J,358.3,34545,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,34545,1,3,0)
+18 ;;=3^Inhalant Related D/O,Unspec
+19 ;;^UTILITY(U,$J,358.3,34545,1,4,0)
+20 ;;=4^F18.99
+21 ;;^UTILITY(U,$J,358.3,34545,2)
+22 ;;=^5133360
+23 ;;^UTILITY(U,$J,358.3,34546,0)
+24 ;;=F18.21^^134^1751^25
+25 ;;^UTILITY(U,$J,358.3,34546,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,34546,1,3,0)
+28 ;;=3^Inhalant Use D/O,Mod/Sev,In Remission
+29 ;;^UTILITY(U,$J,358.3,34546,1,4,0)
+30 ;;=4^F18.21
+31 ;;^UTILITY(U,$J,358.3,34546,2)
+32 ;;=^5003393
+33 ;;^UTILITY(U,$J,358.3,34547,0)
+34 ;;=F18.11^^134^1751^24
+35 ;;^UTILITY(U,$J,358.3,34547,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,34547,1,3,0)
+38 ;;=3^Inhalant Use D/O,Mild,In Remission
+39 ;;^UTILITY(U,$J,358.3,34547,1,4,0)
+40 ;;=4^F18.11
+41 ;;^UTILITY(U,$J,358.3,34547,2)
+42 ;;=^5151305
+43 ;;^UTILITY(U,$J,358.3,34548,0)
+44 ;;=Z00.6^^134^1752^1
+45 ;;^UTILITY(U,$J,358.3,34548,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,34548,1,3,0)
+48 ;;=3^Exam Control in Clinical Research
+49 ;;^UTILITY(U,$J,358.3,34548,1,4,0)
+50 ;;=4^Z00.6
+51 ;;^UTILITY(U,$J,358.3,34548,2)
+52 ;;=^5062608
+53 ;;^UTILITY(U,$J,358.3,34549,0)
+54 ;;=F45.8^^134^1753^13
+55 ;;^UTILITY(U,$J,358.3,34549,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,34549,1,3,0)
+58 ;;=3^Somatoform Symp & Rel D/O,Oth Spec
+59 ;;^UTILITY(U,$J,358.3,34549,1,4,0)
+60 ;;=4^F45.8
+61 ;;^UTILITY(U,$J,358.3,34549,2)
+62 ;;=^331915
+63 ;;^UTILITY(U,$J,358.3,34550,0)
+64 ;;=F45.0^^134^1753^12
+65 ;;^UTILITY(U,$J,358.3,34550,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,34550,1,3,0)
+68 ;;=3^Somatization D/O
+69 ;;^UTILITY(U,$J,358.3,34550,1,4,0)
+70 ;;=4^F45.0
+71 ;;^UTILITY(U,$J,358.3,34550,2)
+72 ;;=^112280
+73 ;;^UTILITY(U,$J,358.3,34551,0)
+74 ;;=F45.9^^134^1753^14
+75 ;;^UTILITY(U,$J,358.3,34551,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,34551,1,3,0)
+78 ;;=3^Somatoform Symp & Rel D/O,Unspec
+79 ;;^UTILITY(U,$J,358.3,34551,1,4,0)
+80 ;;=4^F45.9
+81 ;;^UTILITY(U,$J,358.3,34551,2)
+82 ;;=^5003592
+83 ;;^UTILITY(U,$J,358.3,34552,0)
+84 ;;=F45.1^^134^1753^11
+85 ;;^UTILITY(U,$J,358.3,34552,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,34552,1,3,0)
+88 ;;=3^Somatic Symptom D/O
+89 ;;^UTILITY(U,$J,358.3,34552,1,4,0)
+90 ;;=4^F45.1
+91 ;;^UTILITY(U,$J,358.3,34552,2)
+92 ;;=^5003585
+93 ;;^UTILITY(U,$J,358.3,34553,0)
+94 ;;=F44.4^^134^1753^4
+95 ;;^UTILITY(U,$J,358.3,34553,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,34553,1,3,0)
+98 ;;=3^Conversion D/O w/ Motor Symp or Deficit
+99 ;;^UTILITY(U,$J,358.3,34553,1,4,0)
+100 ;;=4^F44.4
+101 ;;^UTILITY(U,$J,358.3,34553,2)
+102 ;;=^5003579
+103 ;;^UTILITY(U,$J,358.3,34554,0)
+104 ;;=F44.6^^134^1753^1
+105 ;;^UTILITY(U,$J,358.3,34554,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,34554,1,3,0)
+108 ;;=3^Conversion D/O w/ Anesthesia or Sensory Loss
+109 ;;^UTILITY(U,$J,358.3,34554,1,4,0)
+110 ;;=4^F44.6
+111 ;;^UTILITY(U,$J,358.3,34554,2)
+112 ;;=^5003581
+113 ;;^UTILITY(U,$J,358.3,34555,0)
+114 ;;=F44.5^^134^1753^2
+115 ;;^UTILITY(U,$J,358.3,34555,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,34555,1,3,0)
+118 ;;=3^Conversion D/O w/ Attacks or Seizures
+119 ;;^UTILITY(U,$J,358.3,34555,1,4,0)
+120 ;;=4^F44.5
+121 ;;^UTILITY(U,$J,358.3,34555,2)
+122 ;;=^5003580
+123 ;;^UTILITY(U,$J,358.3,34556,0)
+124 ;;=F44.7^^134^1753^3